首药控股-U
(688197)
| 流通市值：25.95亿 | | | 总市值：60.29亿 |
| 流通股本：6400.49万 | | | 总股本：1.49亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,000,000 | 2,000,000 | 2,000,000 | 3,942,025.54 |
| 营业收入 | 2,000,000 | 2,000,000 | 2,000,000 | 3,942,025.54 |
| 二、营业总成本 | 170,147,424.42 | 116,364,461.3 | 58,000,117.07 | 230,281,332.83 |
| 营业成本 | - | - | - | 41,152.61 |
| 税金及附加 | 33,810.32 | 23,065.11 | 10,920.2 | 65,480.32 |
| 管理费用 | 15,339,916.57 | 8,572,040.17 | 4,528,763.8 | 22,814,666.84 |
| 研发费用 | 155,269,560.36 | 108,169,764.5 | 53,635,759.01 | 212,681,411.3 |
| 财务费用 | -495,862.83 | -400,408.48 | -175,325.94 | -5,321,378.24 |
| 其中:利息费用 | 115,459.69 | 87,376.5 | 48,869.37 | 184,166.21 |
| 其中:利息收入 | 614,430.4 | 490,212.47 | 225,393.35 | 5,508,752.18 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 6,047,173.18 | 4,823,463.6 | 2,880,968.1 | 12,082,324.23 |
| 加:投资收益 | 6,756,262.57 | 4,125,490.43 | 2,001,782.75 | 5,266,908.54 |
| 资产减值损失(新) | - | - | - | -8,712,493.59 |
| 信用减值损失(新) | -795,748.14 | 9,118.67 | -100,937.9 | -31,572.01 |
| 其他收益 | 981,771.57 | 743,813.07 | 170,561.42 | 5,798,479.72 |
| 四、营业利润 | -155,157,965.24 | -104,662,575.53 | -51,047,742.7 | -211,935,660.4 |
| 加:营业外收入 | 400,008.85 | 300,008.85 | 300,000 | 1,057.52 |
| 减:营业外支出 | 9,170.7 | 9,170.7 | 3,270.7 | 4,442.37 |
| 五、利润总额 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| 六、净利润 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| 扣除非经常损益后的净利润 | -168,841,741.16 | -114,253,911.23 | -55,999,623.57 | -234,963,393.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -1.04 | -0.7 | -0.34 | -1.43 |
| (二)稀释每股收益 | -1.04 | -0.7 | -0.34 | -1.43 |
| 九、综合收益总额 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| 归属于母公司股东的综合收益总额 | -154,767,127.09 | -104,371,737.38 | -50,751,013.4 | -211,939,045.25 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-28 | 2025-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |